A newly introduced application fee for pharmacists seeking approval to supply pharmaceutical benefits in a new or relocated pharmacy is expected to be $5,500
The Australian Government has set tentative amounts for the new cost recovery application fees announced in the 2018-19 Federal Budget for pharmacists seeking approval to supply pharmaceutical benefits.
These application fees are proposed to cover the cost of regulatory activity related to applications, which includes work undertaken by both the Department of Health and the Australian Community Pharmacy Authority.
The Department of Health expects to introduce the fees from 21 April 2020, subject to official endorsement.
For applications assessed by the Australian Community Pharmacy Authority, the fee is expected to be approximately $5,500 for approval to establish a new pharmacy to supply pharmaceutical benefits or relocate an approved pharmacy (with or without change of ownership).
Meanwhile the fee for applications assessed by the Department of Health is expected to be approximately $900. This fee will apply to applications for approval to change ownership of an approved pharmacy (not involving relocation) and to expand or contract the size of an approved pharmacy.
As the legislation requires that an application must be accompanied by the application fee, an applicant’s payment details must be provided when one of the above application types is submitted to the Department of Health from the commencement date.
Applications from medical practitioners and hospital authorities seeking approval to supply pharmaceutical benefits will not incur a fee.
The introduction date and fee levels outlined above are subject to official endorsement. When the date and fee levels are confirmed, the Department of Health will provide advice via email and on the PBS Approved Suppliers website.
The Department of Health had initially been working towards introducing application fees from 1 July 2019, however this was reportedly delayed as a result of the Federal election on 18 May 2019.